Introduction: Our recent studies on expressed sequence tag (ESTs) derived from cDNA libraries from human fetal, normal adult and osteoarthritic (OA) cartilage showed that Beta-2 microglobulin (B2M) had a high EST expression level in mild and severe OA cartilage (1). B2M is a nonglycosylated polypeptide that is elevated in inflammatory and malignant diseases. It has been shown to induce stromelysin and cyclooxygenase-2 synthesis in human synovial fibroblasts (1, 2). The purpose of this study is to investigate if B2M has a physiological effect on chondrocyte. Methods: Human OA synovial fluid (SF) was collected from human knee joint by aspiration at arthroscopy or total knee replacement. Normal samples were collected from volunteers with no history of knee injury or arthritis. Organ culture: human severe OA cartilage slices were cultured at one slice/well in a 24-well plate in DMEM (Dulbecco's modified Eagle medium), with 10% FCS, 100 units/ml penicillin and 100 mg/ml streptomycin (DMEM++) at 37°C in a humidified atmosphere of 5% CO2. Cultured medium (20 ul) was then collected at different time points for B2M testing. B2M levels in synovial fluid and cartilage organ cultured medium were measured using Beta-2 microglobulin enzyme immunoassay test kit (ALPCO). Statistical significance was assessed by Student's t-test. P value less than 0.05 was considered significant. Cell culture: severe OA chondrocytes were derived from cartilage through collagenase type II digestion. Cells were then seeded at 6.5X10 4 /well (3.2 X10 4 /ml) in a 6-well plate and treated with or without 10 ug/ml B2M (Sigma) for 72 hr. In-house microarrays containing 5184 cDNA clones were used for gene expression profiling.

